During the last session, Tourmaline Bio Inc (NASDAQ:TRML)’s traded shares were 0.34 million, with the beta value of the company hitting 2.27. At the end of the trading day, the stock’s price was $14.38, reflecting an intraday gain of 0.35% or $0.05. The 52-week high for the TRML share is $48.31, that puts it down -235.95 from that peak though still a striking 17.45% gain since the share price plummeted to a 52-week low of $11.87. The company’s market capitalization is $368.74M, and the average trade volume was 258.25K shares over the past three months.
Tourmaline Bio Inc (NASDAQ:TRML) trade information
Tourmaline Bio Inc (TRML) registered a 0.35% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.35% in intraday trading to $14.38, hitting a weekly high. The stock’s 5-day price performance is 9.85%, and it has moved by -10.01% in 30 days. Based on these gigs, the overall price performance for the year is -64.18%.
The consensus price target of analysts on Wall Street is $50, which implies an increase of 71.24% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $50 and $50 respectively. As a result, TRML is trading at a discount of -247.71% off the target high and -247.71% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.23%. While earnings are projected to return 67.33% in 2025, the next five years will return 21.46% per annum.
TRML Dividends
Tourmaline Bio Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 2.22 million shares, is of AVORO CAPITAL ADVISORS LLC’s that is approximately 8.6387% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $28.58 million.
Also, the Mutual Funds coming in first place with the largest holdings of Tourmaline Bio Inc (TRML) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 646.41 shares. This amounts to just over 2.52 percent of the company’s overall shares, with a $9.3 million market value. The same data shows that the other fund manager holds slightly less at 620.32, or about 2.42% of the stock, which is worth about $8.92 million.
